ARCHIVES

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Childhood Cancer Survivors Do Not Have an Increased Risk Of Passing On Birth Defects

December 30, 2011

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

NCI Payline For Fiscal 1986 To Be 160 or 165

October 11, 1985

DCPC Board Approves New Intramural Laboratory for Diet And Nutrition; NCAB to Consider It Next

May 22, 1987